PTEN and endometrium neoplasm: We speculate that, although the very low expression level of PTEN-R173C from the endogenous allele may not be detectable by immunohistochemistry, it is still sufficient to partially downregulate PI3K signalling and AKT P-S473 and thereby prevent the development of endometrial tumours.